News and Press Releases

At MD&M Minneapolis, TekniPlex Healthcare to Highlight Concept-to-Commercialization Capabilities for Class III Implantable Devices and Delivery Systems

Comprehensive services punctuated by precision, tight-tolerance metalworking expertise and injection molding solutions; company also will display range of medical tubing such as catheter-based systems, as well as select medical device...

Category: Drug Delivery, Manufacturing and Packing, Other
Posted: September 18, 2024

Industrielaan 37 B-9320 Erembodegem Belgium Tel: +32 (0)53 650711 VAT 0425.537.515

AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease

Prescreening rate of Phase 2b ReTain trial triggers clinical development milestone payment in September Potentially registrational trial is targeting enrollment of approximately 500 participants with pre-symptomatic AD FDA Fast Track...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 17, 2024

EPFL Innovation Park-Building B 1015 Lausanne / Switzerland

Biocair increases customer support with the expansion of its Hamburg site

September 17 2024 – Hamburg, Germany –Benefitting from close links to the airport, Biocair’s Hamburg facility now offers an enhanced package of support following an expansion. As a leading global...

Category: Logistics
Posted: September 17, 2024

Iconix One, Iconix Park, London Road Sawston Cambridge CB22 3EG

Inauguration of the New Richter BioLogics cGMP Facility for the Manufacture of Biopharmaceuticals for the Global Market

September 17 2024 –BOVENAU, Germany, – Richter BioLogics GmbH & Co KG, the microbial biologics affiliate of Gedeon Richter Plc. celebrated the opening of its new cutting-edge biopharmaceutical cGMP facility in...

Category: BioManufacturing
Posted: September 17, 2024

Northway’s 20th birthday was celebrated at Sapiehas Palace with famous guests

14 September 2024 –Vilnius, Lithuania – On Thursday evening, around 100 guests gathered at the Sapiehas Palace in Vilnius to celebrate the 20th birthday of the „Northway Group“. Today, the group crosses not...

Category: Biotechnology
Posted: September 16, 2024

Darolutamide plus androgen deprivation therapy significantly reduced the risk of radiological progression or death by 46% compared to placebo plus ADT in patients with metastatic hormone-sensitive prostate cancer

Results from the pivotal Phase III ARANOTE trial evaluating darolutamide plus androgen deprivation therapy (ADT) showed a statistically significant increase in radiological progression-free survival (rPFS) compared to placebo plus ADT...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 16, 2024

Orion Corporation Orionintie 1A, FI-02200 Espoo P.O.Box 65, FI-02101 Espoo

Novartis Kisqali shows deepening benefit in new analysis, reducing the risk of recurrence by 28.5% in a broad population of patients with early breast cancer

Invasive disease-free survival benefit continued to increase after completion of the three-year treatment period across all patient subgroups, including those with node-negative disease Results remain consistent across secondary endpoints, including...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 16, 2024

Book a meeting with Gaelic Laboratories at CPHI Milan!

Gaelic Laboratories is pleased to be exhibiting at CPHI Milan. Visit us in Hall 5 to learn more about our advanced Beta-Lactam manufacturing and packaging facilities, and our newly-equipped laboratories...

Category: Biotechnology, Drug Discovery
Posted: September 16, 2024

Old Waterford Rd, Gurtnafleur, Clonmel, Co. Tipperary, E91 CD92 Ireland

ILC Therapeutics completes £2.5m financing and bolsters C-suite

Owain Millington appointed CEO, Julie Bailey appointed CFO and Dawn Firmin appointed COO Financing to support pre-clinical development of ILCT’s two lead assets 11 September 2024 -- Glasgow, UK --...

Category:
Posted: September 13, 2024

75 King William Street London EC4N 7BE

CPHI Annual Report 2024: CPHI Milan Report predicts BLA and Tides approvals will surpass small molecules within the next three years

Bio and Tides predicted to be the fastest growing modality for CDMOs over the next five years 12 September 2024 – Milan, Italy – Ahead of CPHI Milan – the...

Category: Pharmaceutical
Posted: September 12, 2024

5 Howick Place, London SW1P 1WG

KADANS SCIENCE PARTNER WELCOMES NEW TENANT MYRICX BIO TO LONDON INNOVATION CENTRE AT CANARY WHARF

Myricx Bio joins Kadans’ pioneering innovation centre in Canary Wharf, providing the facilities for its future expansion and pipeline progression, following a recent £90m Series A financing 12 September 2024:...

Category: BioManufacturing, Biotechnology
Posted: September 12, 2024

Rijksweg 5 5076 PB Haaren The Netherlands

PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific

Collaboration Aims to Harness HiFi Sequencing to Improve Diagnosis and Treatment of Subfertility and Recurrent Pregnancy Loss HiFi Solves Sub-fertility Consortium, an innovative collaboration involving five leading centers across the...

Category: Biotechnology, Other
Posted: September 12, 2024

1305 O’Brien Drive Menlo Park, CA 94025

Andrew MacGarvey & Conditor Capital Launch Coronado Research to maximise the use of data and technology in drug development; Dr Nicholas Edwards announced as Chair

10 September 2024 – London, UK Coronado Research is a consultancy-led, professional services organisation operating in the clinical development arena. The company will help pharmaceutical and biotechnology companies optimise their drug...

Category:
Posted: September 11, 2024

MicrosensDx collaborates with Imperial researchers to develop groundbreaking sepsis test

11 September 2024 -- Cambridge, UK -- MicrosensDx is excited to announce that it is working with The Mayr Group at Imperial College London to develop a novel biomarker test...

Category: Biotechnology, Other
Posted: September 11, 2024

204 Cambridge Science Park, Milton Road, Cambridge, CB4 0GZ

Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors

Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones 11 Sep 2024 -- London, UK -- Closed Loop Medicine Ltd.,...

Category: Biotechnology, Other, Pharmaceutical
Posted: September 11, 2024

Babraham Research Campus Cambridge CB22 3AT United Kingdom